IMMUNIZATION AGAINST SARS-COV-RELATED DISEASES

The invention provides long immunogenic peptides for treating diseases related to severe acute respiratory syndrome coronaviruses, such as SARS-CoV-2 or SARS-CoV-1. The invention also provides immunogenic compositions and vaccines comprises long immunogenic peptides of the invention and method of th...

Full description

Saved in:
Bibliographic Details
Main Authors Wiekmeijer, Anna-Sophia, Melief, Cornelis Johannes Maria, Molenaar, Miranda Bernardina Johanna, Hooftman, Leonard Willem Frederik, Beenakker, Thomas Johannes Maria, van Rijn, Peter
Format Patent
LanguageEnglish
Published 11.05.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides long immunogenic peptides for treating diseases related to severe acute respiratory syndrome coronaviruses, such as SARS-CoV-2 or SARS-CoV-1. The invention also provides immunogenic compositions and vaccines comprises long immunogenic peptides of the invention and method of therapeutic treatment or prevention of SARS-CoV-related diseases comprising administration of immunogenic peptides according to the invention.
Bibliography:Application Number: US202117920416